Evidence map›Paper›PMID 41031391›Full record

ArticleFrontiers in allergy2025

Efficacy and safety of a 4-step versus a 5-step egg ladder in children with IgE-mediated hen's egg protein allergy: protocol for an open-label randomized controlled trial.

Andrea Horvath, Anna Bujnowska, Agata Stróżyk, Maria Zemła, Anna Nowak-Węgrzyn, Katarzyna Grzela, Joanna Jerzyńska, Hania Szajewska

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07040111 (Efficacy and Safety of a 4-Step Versus a 5-Step Egg Ladder in Children With IgE-Mediated Hen's Egg Protein Allergy), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07040111 nanot yet recruitingnot on this map

Efficacy and Safety of a 4-Step Versus a 5-Step Egg Ladder in Children With IgE-Mediated Hen's Egg Protein Allergy: Protocol for an Open-Label Randomized Controlled Trial

TypeinterventionalSponsorMedical University of WarsawRan2025 to 2028Enrolled94ConditionsFood Allergy, Egg Allergy, Hen Egg AllergyArmsoral food challenge (OFC)
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrea HorvathDepartment of Paediatrics, Medical University of Warsaw, Warsaw, Poland.
Anna BujnowskaDepartment of Paediatrics, Medical University of Warsaw, Warsaw, Poland.
Agata StróżykDepartment of Paediatrics, Medical University of Warsaw, Warsaw, Poland.
Maria ZemłaDepartment of Paediatrics, Medical University of Warsaw, Warsaw, Poland.
Anna Nowak-WęgrzynDepartment of Paediatrics, Hassenfeld Children's Hospital, New York University Grossman School of Medicine, New York City, NY, United States.
Katarzyna GrzelaDepartment of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland.
Joanna JerzyńskaDepartment of Pediatrics and Allergy, Korczak Pediatric Center, Medical University of Lodz, Lodz, Poland.
Hania SzajewskaDepartment of Paediatrics, Medical University of Warsaw, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Introducing baked egg into the diet of children with hen's egg allergy (HEA) has been shown to potentially accelerate the development of tolerance to non-heated egg. However, there is no standardized egg ladder (EL) protocol, and different scientific societies across countries recommend varying versions. This study aims to assess the efficacy and safety of the four-step EL (4-EL) compared with the five-step EL (5-EL) in children with IgE-mediated HEA. Methods: We will perform an open-label randomized trial with two-parallel arms in two departments if the same academic hospital. A total of 84 children with IgE-mediated HEA will be allocated in 1:1 ratio to introduce hen's egg allergy into their diet according to either 4-EL or 5-EL with 4-week break period between subsequent steps. Oral food challenge (OFC) with tested products at each subsequent step of the EL will be conducted in hospital settings. The primary outcome will be the percentage of children with tolerance to non-heated hen's egg proteins defined as non-allergic reaction to raw hen's egg (0.5-1 egg, depending on the age of the patient) during the last OFC; measured at the end of the 18-week observation period for the 4-EL and 24-week observation period for the 5-EL. Secondary outcomes will include the percentage of children with negative OFC to each EL step; the percentage of children with anaphylaxis (including the percentage of those who were treated with epinephrine); the percentage of children with exacerbation of atopic dermatitis; growth; compliance; and quality of life of the caregivers and parents anxiety about adverse events during their child's OFC. Discussion: This rigorously designed RCT will provide evidence on the efficacy and safety of the 4-EL in children with IgE-mediated HEA. The findings will inform guideline development groups and further confirmatory trials. Trial Registration Number: NCT07040111, date of registration: 27 June 2025.

Indexed as

childrenegg ladderfood allergyIgE-mediated hen's egg allergypaediatrics

Identifiers

PMID41031391
PMCPMC12477030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.